Arcadia Biosciences, Inc.(RKDA)— Stock Profile, AI Score & Financials
Energy · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Arcadia Biosciences, Inc. (RKDA) stock profile, AI quality score, and SEC EDGAR financial data, a Energy sector company. 13F Pro's AI-powered ranking engine scores RKDA at 12.1/100 on a 32-signal composite quality model, placing it at rank #2,890 of 2,962 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Arcadia Biosciences, Inc. reports quarterly revenue of $1.4M, net income of $-6.3M. Top institutional holders of RKDA by reported 13-F value include HRT FINANCIAL, CITADEL ADVISORS, Virtu Financial, based on the most recent SEC filings. RKDA trades on the Nasdaq exchange and files with the SEC under CIK 1469443. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate RKDA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Arcadia Biosciences, Inc. directly from SEC EDGAR.
AI Quality Score
12.1/100
AI Rank
#2,890
Revenue
$1.4M
Net Income
$-6.3M
RKDA key financials by period
Arcadia Biosciences, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$4.9M
$-2.3M
-51.5%
FY 2024
10-K
$5.0M
$-7.0M
-72.3%
FY 2023
10-K
$4.5M
$-14.0M
-137.0%
FY 2022
10-K
$7.4M
$-15.4M
-188.8%
FY 2021
10-K
$6.8M
$-14.7M
—
FY 2020
10-K
$8.0M
$-4.7M
-159.1%
Institutions holding RKDA
Institutional investors reporting a position in Arcadia Biosciences, Inc. on SEC Form 13F.
